Learn the New Atrial Fibrillation Guidelines
The new classification recognizes atrial fibrillation as a disease continuum and emphasizes a holistic approach to management.
What is White Lung Pneumonia?
White lung pneumonia, also known as pediatric white lung syndrome, is not exactly a novel pneumonia of unknown origin.
Misrepresenting Physicians in Court
Dr. Ruan explains how the misapplication of the Controlled Substance Act enabled judicial misconduct and led to his conviction.
Focusing on the Jury Instruction on Drug Conspiracy at My Trial
Dr. Ruan explains how biased jury instructions can lead to biased outcomes in criminal cases involving physicians' prescribing behavior.
Nikki Haley’s Influence on Abortion
Nikki Haley is having a political moment. How will her beliefs shape Conservative perspectives on abortion?
Suicide Rates Reach New High
Suicide rates in the United States have seen an alarming rise in recent years, highlighting the urgent need for a ...
Protect Your Medical Credentials
Although Dr. Sasaki didn’t know what was actually going on, he became suspicious after another doctor told him that something ...
Trumpism and the Patient Physician Relationship
With the 2024 election approaching, it is crucial to understand the changing dynamics and the implications for patient autonomy.
Healthcare is Health Justice
I have spent the past thirteen years navigating the healthcare system like many who become disabled due to high-impact chronic ...
A Cornucopia of Vaccines
It feels like vaccines are everywhere. Every news cycle seems to introduce a new vaccine or vaccine formulary. But how ...
Aggressive and Impulsive Behavior on Black Friday
A little known condition explains Black Friday behavior, notorious for its shopping frenzy, with shoppers displaying aggressive behavior.
Understanding Contributors to US Drug-Related Mortality
To understand the real contributors to US drug-related mortality, it is important to examine mortality data in detail.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more